Ribavirin treatment for hepatitis C may artificially lower HbA1c and give misleading information about glycaemic control
No takes yet. Share an insight, caveat, or question.
Michael Robertson (2008) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: